TELO
Telomir Pharmaceuticals, Inc.
0.5950
+0.02 (+2.73%)
52w low 0.5450
1.58 high
4.8% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 854.15K | 3.94M | 12.24M | 10.54M | |
| R&D | 833.21K | 1.57M | 2.24M | 2.44M | |
| SG&A | 20.94K | 600.19K | 9.64M | 8.10M | |
| Operating Income | -854.15K | -3.94M | -12.24M | -10.54M | |
| EBITDA | -854.15K | -11.43M | -12.19M | -10.41M | |
| Pretax Income | -854.15K | -13.07M | -16.53M | -10.41M | |
| Net Income | -854.15K | -13.07M | -16.53M | -10.41M | |
| EPS Diluted | -0.03 | -0.44 | -0.56 | -0.33 | |
| Diluted Shares | 29.61M | 29.61M | 29.54M | 31.65M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--